DE69116240T2 - Verfahren zur Herstellung von Zellprotein mit Anti-HIV-Wirkung - Google Patents

Verfahren zur Herstellung von Zellprotein mit Anti-HIV-Wirkung

Info

Publication number
DE69116240T2
DE69116240T2 DE69116240T DE69116240T DE69116240T2 DE 69116240 T2 DE69116240 T2 DE 69116240T2 DE 69116240 T DE69116240 T DE 69116240T DE 69116240 T DE69116240 T DE 69116240T DE 69116240 T2 DE69116240 T2 DE 69116240T2
Authority
DE
Germany
Prior art keywords
protein
hiv activity
cells
production
cell protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69116240T
Other languages
English (en)
Other versions
DE69116240D1 (de
Inventor
Meihan Nonoyama
Akiko Tanaka
Partrick K Lai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TAMPA BAY RESEARCH INST
Original Assignee
TAMPA BAY RESEARCH INST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TAMPA BAY RESEARCH INST filed Critical TAMPA BAY RESEARCH INST
Publication of DE69116240D1 publication Critical patent/DE69116240D1/de
Application granted granted Critical
Publication of DE69116240T2 publication Critical patent/DE69116240T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0694—Cells of blood, e.g. leukemia cells, myeloma cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69116240T 1990-06-20 1991-06-18 Verfahren zur Herstellung von Zellprotein mit Anti-HIV-Wirkung Expired - Fee Related DE69116240T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54097390A 1990-06-20 1990-06-20
US07/659,564 US5346988A (en) 1990-06-20 1991-02-22 Process for obtaining cellular protein having anti-HIV activity

Publications (2)

Publication Number Publication Date
DE69116240D1 DE69116240D1 (de) 1996-02-22
DE69116240T2 true DE69116240T2 (de) 1996-05-23

Family

ID=27066570

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69116240T Expired - Fee Related DE69116240T2 (de) 1990-06-20 1991-06-18 Verfahren zur Herstellung von Zellprotein mit Anti-HIV-Wirkung

Country Status (5)

Country Link
US (2) US5346988A (de)
EP (1) EP0462792B1 (de)
AT (1) ATE132875T1 (de)
DE (1) DE69116240T2 (de)
ES (1) ES2082140T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346988A (en) * 1990-06-20 1994-09-13 Tampa Bay Research Institute Process for obtaining cellular protein having anti-HIV activity
AU3210195A (en) * 1994-08-04 1996-03-04 Tampa Bay Research Institute Protein having anti-retrovirus activity and method for obtaining it
US5643881A (en) * 1994-08-04 1997-07-01 Tampa Bay Research Institute Protein having anti-HIV activity and method for obtaining it
RU2172322C1 (ru) 1999-12-27 2001-08-20 Энтофарм Ко., Лтд. Аллофероны-иммуномодулирующие пептиды
US7760823B2 (en) * 2003-12-29 2010-07-20 Nokia Corporation Apparatus, and associated method, for detecting packets
RU2276988C2 (ru) * 2004-01-15 2006-05-27 Сергей Иванович Черныш Антивирусное вещество

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683199A (en) * 1983-01-31 1987-07-28 Sloan-Kettering Institute For Cancer Research Interleukin-2 dependent cytotoxic T-cell clones
JPS59181293A (ja) * 1983-03-31 1984-10-15 Kyowa Hakko Kogyo Co Ltd 新規生理活性蛋白性物質
JPS6062997A (ja) * 1983-09-17 1985-04-11 Mochida Pharmaceut Co Ltd インタ−フエロンの生産方法
EP0193032A3 (de) * 1985-02-13 1988-04-06 Gesellschaft für Biotechnologische Forschung mbH (GBF) Zusammensetzung umfassend oder enthaltend Cytokin, Herstellungsverfahren, DNA-Sequenz und deren Verwendung
US5039794A (en) * 1986-09-19 1991-08-13 Otsuka Pharmaceutical Co., Ltd. Tumor egress factor and processes for producing the same
US4985249A (en) * 1987-06-26 1991-01-15 Hiroshi Sakagami Anti-HIV agents
JPS6490199A (en) * 1987-09-30 1989-04-06 Hiromi Fujiwara T cell growth factor derived from thymic interstitial cell and production thereof
US5346988A (en) * 1990-06-20 1994-09-13 Tampa Bay Research Institute Process for obtaining cellular protein having anti-HIV activity
US5236829A (en) * 1990-12-10 1993-08-17 The Johns Hopkins University Method of producing monokine induced by gamma interferon

Also Published As

Publication number Publication date
EP0462792A3 (en) 1992-05-27
EP0462792B1 (de) 1996-01-10
US5480782A (en) 1996-01-02
EP0462792A2 (de) 1991-12-27
US5346988A (en) 1994-09-13
DE69116240D1 (de) 1996-02-22
ES2082140T3 (es) 1996-03-16
ATE132875T1 (de) 1996-01-15

Similar Documents

Publication Publication Date Title
DK0451611T3 (da) Human hæmatopoietisk stamcelle
ATE209679T1 (de) Proteine mit faktor viii aktivität, verfahren zu deren herstellung unter verwendung von genetisch modifizierten zellen und diese enthaltende zusammensetzungen
DE3280479D1 (de) Rekombinante DNS-Mittel und Verfahren
DE3689196D1 (de) Verfahren zur Herstellung von Amiden unter Verwendung von Mikroorganismen.
ATE46358T1 (de) Verfahren zur zuechtung von lyophilisierten mikroorganismen.
DE69109886T2 (de) Verfahren zur Herstellung von humanem Faktor VIII und dessen Analogen.
ATE75775T1 (de) Verfahren zur herstellung von biologisch aktivem plasminogenaktivator.
DE3787551D1 (de) Proteinproduktion mittels zellkultur.
DE69116240D1 (de) Verfahren zur Herstellung von Zellprotein mit Anti-HIV-Wirkung
EP0380692A4 (en) Plant tissue culture process
ATE82985T1 (de) Strukturelles phosphoprotein (pp 150) des menschlichen cytomegalovirus, seine herstellung und verwendung.
DE69430975T2 (de) Verfahren zur Herstellung von Proteinen
KR890005272A (ko) 흉선 간질-유래 t세포 성장인자 및 그의 제조방법
DE59105850D1 (de) Mikrobiologisches Verfahren zur Herstellung von hydroxylierten Heterocyclen.
ATE82319T1 (de) Verfahren zur herstellung von aktivierten toetenden zellen.
EP0672684A4 (de) Neuer megakaryot-kolonie-stimulierender faktor und seine herstellung.
ATE60802T1 (de) Mikrobiologisches verfahren zur herstellung von menschlichem lysozym.
DE69004964D1 (de) Zellenzuchtverfahren für die produktion von aktiviertem protein-c.
DE69905218D1 (de) Verfahren zur Herstellung von L-Allysin Acetal
FR2555577B1 (fr) Nouveaux derives de peptides, leur procede de preparation et leur emploi comme reactif biologique
ATE73125T1 (de) Verfahren zur herstellung von dialkylaminoethylaminen.
ATE81530T1 (de) Verfahren zur fermentativen herstellung von laminos|uren aus alpha-ketocarbonsaeuren.
DE59004397D1 (de) Verfahren zur Kultivierung von Zellen in Mikrohohlkugeln.
ATE115183T1 (de) Zellzüchtungsverfahren.
ATE49777T1 (de) Verfahren zur zuechtung von hepatozyten und cozuechtung von hepatozyten und von behandelten epithelien leberzellen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee